Company
Vexim
Last checked: Nov 20, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations
FDA decisions since 2015
1
510(k), De Novo and PMA
Device trials
2
As lead sponsor, any status
Adverse event reports
0
Received Nov 1, 2025 to Nov 20, 2026
Recall records
0
One per recalled product
This company is not on our public-company list, so only this exact name is matched. Naming a company here is not a recommendation of it or of any security.
Financing
From SEC filings.
We found no SEC financing filings under the name Vexim, so its financing is unknown here. That is common for companies based outside the US, for subsidiaries of larger companies, and for companies funded by founders, grants or customers. A company that changed its name can also be missed.
Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys.
Investors
5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors in private rounds are not in public filings.
No 5%+ shareholder filings or SBIR grants found under the name Vexim.
Latest FDA decisions
- SpineJack Expansion Kit510(k)
K181262 · Decided Aug 30, 2018 · 111 days after receipt
Device type: Cement, Bone, Vertebroplasty (NDN) · Orthopedic Surgery
Device trials
Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.
- SpineJack® Versus Conservative Treatment Study (SPICO Study)Pivotal-lookingCompleted
NCT02657265 · 100 participants · Start Jan 13, 2016 · Primary completion May 27, 2019
Device: SpineJack system; Conservative management · For: Spinal Fractures; Vertebral Compression Fractures; Back Injuries and 1 more
Sites: Besançon, France; Bordeaux, France; Brest, France · 9 sites in all
- Prospective Comparative Study to Compare Safety and Effectiveness of Two Vertebral Compression Fracture Reduction TechniquesPivotal-lookingCompleted
NCT02461810 · 152 participants · Start Apr 2015 · Primary completion Feb 20, 2018
Device: Vertebral fracture surgery SpineJack® · For: Spinal Fractures; Vertebral Compression Fractures; Back Injuries and 1 more
Sites: Besançon, France; Brest, France; Marseille, France · 13 sites in all
Reports received
0
Received Nov 1, 2025 to Nov 20, 2026
Malfunction reports
0
Injury reports
0
Death reports
0
Adverse event reports received per month
Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.
No reports to chart for this view.
Device types named most often
Last 12 months, by FDA product code. A company that sells more gets more reports.
No device types to rank.
Brand names named most often
Last 12 months, as written on the reports. One product can appear under several spellings.
No brand names to rank.
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recalls under this name in FDA's data.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.